1. Home
  2. TNGX vs AISPW Comparison

TNGX vs AISPW Comparison

Compare TNGX & AISPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • AISPW
  • Stock Information
  • Founded
  • TNGX 2014
  • AISPW N/A
  • Country
  • TNGX United States
  • AISPW United States
  • Employees
  • TNGX N/A
  • AISPW 47
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • AISPW Blank Checks
  • Sector
  • TNGX Health Care
  • AISPW Finance
  • Exchange
  • TNGX Nasdaq
  • AISPW Nasdaq
  • Market Cap
  • TNGX 990.5M
  • AISPW N/A
  • IPO Year
  • TNGX N/A
  • AISPW 2021
  • Fundamental
  • Price
  • TNGX $9.89
  • AISPW $0.38
  • Analyst Decision
  • TNGX Strong Buy
  • AISPW
  • Analyst Count
  • TNGX 8
  • AISPW 0
  • Target Price
  • TNGX $14.86
  • AISPW N/A
  • AVG Volume (30 Days)
  • TNGX 822.0K
  • AISPW N/A
  • Earning Date
  • TNGX 08-05-2024
  • AISPW N/A
  • Dividend Yield
  • TNGX N/A
  • AISPW N/A
  • EPS Growth
  • TNGX N/A
  • AISPW N/A
  • EPS
  • TNGX N/A
  • AISPW N/A
  • Revenue
  • TNGX $37,232,000.00
  • AISPW N/A
  • Revenue This Year
  • TNGX N/A
  • AISPW N/A
  • Revenue Next Year
  • TNGX $2.40
  • AISPW N/A
  • P/E Ratio
  • TNGX N/A
  • AISPW N/A
  • Revenue Growth
  • TNGX 49.72
  • AISPW N/A
  • 52 Week Low
  • TNGX $2.88
  • AISPW N/A
  • 52 Week High
  • TNGX $13.03
  • AISPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 59.16
  • AISPW N/A
  • Support Level
  • TNGX $9.26
  • AISPW N/A
  • Resistance Level
  • TNGX $9.96
  • AISPW N/A
  • Average True Range (ATR)
  • TNGX 0.66
  • AISPW 0.00
  • MACD
  • TNGX -0.00
  • AISPW 0.00
  • Stochastic Oscillator
  • TNGX 88.99
  • AISPW 0.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About AISPW Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.

Share on Social Networks: